Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association.
Editor-in-chief, Alan Farwell, MD
Available in pdf format for saving and printing and Web page format for viewing online
PDF Format for Saving and Printing
Clinical Thyroidology for the Public Volume 8 Issue 4 (PDF file, 746 KB)
TABLE OF CONTENTS – Web Format
AUTOIMMUNE THYROID DISEASE Thyroid antibodies are frequently detected in patients with type 1 diabetes mellitus
Benvenga S, et al. Serum thyroid hormone autoantibodies in type 1 diabetes mellitus. J Clin Endocrinol Metab [Epub ahead of print] (PDF File for saving and printing, 86 KB)
THYROID EYE DISEASE Cholesterol lowering medications and thyroidectomy may reduce the risk of thyroid eye disease
Stein JD et al. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. JAMA Ophthalmol. December 11, 2014 [epub] (PDF File for saving and printing, 70 KB)
THYROID CANCER BRAF V600 mutations are common but may not predict survival in thyroid cancer
Niederer-Wüst S et al. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer. Surgery 2015;157:119-25.
(PDF File for saving and printing, 170 KB)
THYROID CANCER Higher initial doses of radioactive iodine therapy for thyroid cancer may decrease recurrence and improve long-term survival in older patients
Verburg FA et al. Long-term survival in differentiated thyroid cancer is worse after low activity initial post-surgical 131I therapy in both high- and low-risk patients. J Clin Endocrinol Metab 2014;99:4487-96
(PDF File for saving and printing, 69 KB)
THYROID CANCER Survival prognosis in metastatic thyroid cancer
Wang LY et al. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer. Thyroid. September 24, 2014 [Epub ahead of print].
(PDF File for saving and printing, 718 KB)